|Articles|September 1, 2012
- Pharmaceutical Executive-09-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2012
Busting the Tape
Advertisement
Articles in this issue
about 14 years ago
Pharm Exec's 11th Annual Industry Auditabout 14 years ago
Patients Wade Into the Pricing Debateabout 14 years ago
The Endless Treadmill of End-of-Life Careabout 14 years ago
The Power of Patient Feedbackabout 14 years ago
The Payer C Change: From Customers to Competitorsabout 14 years ago
The Margin Callabout 14 years ago
Open Innovation in Pharma: Defining the DialogueAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
The Agentic AI Revolution in Biopharma
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5